P42866 (OPRM_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 97.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Mu-type opioid receptor Short name=M-OR-1 Short name=MOR-1 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus |
Protein attributes
| Sequence length | 398 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Receptor for beta-endorphin. |
| Subunit structure | Forms a complex with G(alpha)z/i2 subunits and the RGSZ proteins, RGSZ17 and RGSZ20. The formation of this complex results in mu-opioid receptor desensitization. Interacts with RGSZ17 and RGSZ20. Ref.4 |
| Subcellular location | |
| Sequence similarities | Belongs to the G-protein coupled receptor 1 family. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Membrane |
| Domain | Transmembrane Transmembrane helix |
| Molecular function | G-protein coupled receptor Receptor Transducer |
| PTM | Disulfide bond Glycoprotein Lipoprotein Palmitate Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | activation of adenylate cyclase activity by dopamine receptor signaling pathway Inferred from direct assay. Source: MGI inhibition of adenylate cyclase activity by G-protein signaling pathwayInferred from direct assay. Source: MGI locomotory behaviorInferred from genetic interaction. Source: MGI |
| Cellular component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW membrane fractionInferred from direct assay. Source: MGI plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | opioid receptor activity Inferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 398 | 398 | Mu-type opioid receptor | PRO_0000069975 | |||||||
Regions | |||||||||||
| Topological domain | 1 – 64 | 64 | Extracellular Potential | ||||||||
| Transmembrane | 65 – 94 | 30 | Helical; Name=1; Potential | ||||||||
| Topological domain | 95 – 103 | 9 | Cytoplasmic Potential | ||||||||
| Transmembrane | 104 – 121 | 18 | Helical; Name=2; Potential | ||||||||
| Topological domain | 122 – 143 | 22 | Extracellular Potential | ||||||||
| Transmembrane | 144 – 163 | 20 | Helical; Name=3; Potential | ||||||||
| Topological domain | 164 – 193 | 30 | Cytoplasmic Potential | ||||||||
| Transmembrane | 194 – 209 | 16 | Helical; Name=4; Potential | ||||||||
| Topological domain | 210 – 234 | 25 | Extracellular Potential | ||||||||
| Transmembrane | 235 – 257 | 23 | Helical; Name=5; Potential | ||||||||
| Topological domain | 258 – 280 | 23 | Cytoplasmic Potential | ||||||||
| Transmembrane | 281 – 303 | 23 | Helical; Name=6; Potential | ||||||||
| Topological domain | 304 – 311 | 8 | Extracellular Potential | ||||||||
| Transmembrane | 312 – 328 | 17 | Helical; Name=7; Potential | ||||||||
| Topological domain | 329 – 398 | 70 | Cytoplasmic Potential | ||||||||
Amino acid modifications | |||||||||||
| Lipidation | 351 | 1 | S-palmitoyl cysteine Potential | ||||||||
| Glycosylation | 9 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 31 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 38 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 46 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 140 ↔ 217 | By similarity | |||||||||
Experimental info | |||||||||||
| Sequence conflict | 22 | 1 | C → W in AAA86878. Ref.3 | ||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene." Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., Loh H.H. Proc. Natl. Acad. Sci. U.S.A. 91:9081-9085(1994) [PubMed: 8090773] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Strain: C57BL/6. Tissue: Liver. |
| [2] | "Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor." Rossi G.C., Pan Y.X., Brown G.P., Pasternak G.W. FEBS Lett. 369:192-196(1995) [PubMed: 7649256] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain. |
| [3] | "Characterization of the murine mu opioid receptor gene." Kaufman D.L., Keith D.E., Anton B., Tian J., Magendzo K., Newman D., Tran T., Lee D.S., Wen C., Xia Y., Lusis A.J., Evans C.J. J. Biol. Chem. 270:15877-15883(1995) [PubMed: 7797593] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Strain: BALB/c. Tissue: Brain. |
| [4] | "The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins." Garzan J., Rodriguez-Munoz M., Lopez-Fando A., Sanchez-Blazquez P. Neuropsychopharmacology 30:1632-1648(2005) [PubMed: 15827571] [Abstract] Cited for: INTERACTION WITH RGS17 AND RGS20. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U10561 U10560 Genomic DNA. Translation: AAB60673.1.U26915 mRNA. Translation: AAA81170.1. U19380 mRNA. Translation: AAA86878.1. |
| IPI | IPI00831334. |
| PIR | A57510. |
| UniGene | Mm.457998. |
3D structure databases | |
| ProteinModelPortal | P42866. |
| SMR | P42866. Positions 69-352. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-46148N. |
| STRING | P42866. |
Protein family/group databases | |
| GPCRDB | Search... |
PTM databases | |
| PhosphoSite | P42866. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000056385; ENSMUSP00000060590; ENSMUSG00000000766. ENSMUST00000092728; ENSMUSP00000090404; ENSMUSG00000000766. ENSMUST00000092734; ENSMUSP00000090410; ENSMUSG00000000766. ENSMUST00000105607; ENSMUSP00000101232; ENSMUSG00000000766. |
Organism-specific databases | |
| MGI | MGI:97441. Oprm1. |
Phylogenomic databases | |
| HOVERGEN | HBG106919. |
Gene expression databases | |
| ArrayExpress | P42866. |
| Bgee | P42866. |
| CleanEx | MM_OPRM1. |
| Genevestigator | P42866. |
| GermOnline | ENSMUSG00000000766. Mus musculus. |
Family and domain databases | |
| InterPro | IPR000276. 7TM_GPCR_Rhodpsn. IPR017452. GPCR_Rhodpsn_supfam. IPR000105. Mu_opioid_rcpt. IPR001418. Opioid_rcpt. [Graphical view] |
| Pfam | PF00001. 7tm_1. 1 hit. [Graphical view] |
| PRINTS | PR00237. GPCRRHODOPSN. PR00537. MUOPIOIDR. PR00384. OPIOIDR. |
| PROSITE | PS00237. G_PROTEIN_RECEP_F1_1. 1 hit. PS50262. G_PROTEIN_RECEP_F1_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| SOURCE | Search... |
Entry information
| Entry name | OPRM_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P42866 Secondary accession number(s): Q60768 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| 7-transmembrane G-linked receptors List of 7-transmembrane G-linked receptor entries |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with